Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Price:
23.92
HKD
-1.16%
Market Closed
Market Cap:
HK$8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
CN |
|
Huntington Bancshares Inc
NASDAQ:HBAN
|
US |
|
T
|
Takachiho Koheki Co Ltd
TSE:2676
|
JP |
Income Statement
Earnings Waterfall
Zylox-Tonbridge Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Income Statement
Zylox-Tonbridge Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
|
| Revenue |
178
N/A
|
259
+46%
|
334
+29%
|
411
+23%
|
528
+28%
|
664
+26%
|
782
+18%
|
898
+15%
|
1 057
+18%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(46)
|
(64)
|
(81)
|
(104)
|
(143)
|
(188)
|
(223)
|
(256)
|
(295)
|
|
| Gross Profit |
132
N/A
|
195
+48%
|
253
+29%
|
308
+22%
|
385
+25%
|
475
+23%
|
560
+18%
|
642
+15%
|
763
+19%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(350)
|
(415)
|
(476)
|
(536)
|
(533)
|
(496)
|
(489)
|
(520)
|
(581)
|
|
| Selling, General & Administrative |
(193)
|
(214)
|
(241)
|
(266)
|
(269)
|
(269)
|
(257)
|
(276)
|
(316)
|
|
| Research & Development |
(162)
|
(207)
|
(223)
|
(261)
|
(248)
|
(222)
|
(225)
|
(245)
|
(247)
|
|
| Depreciation & Amortization |
(9)
|
(11)
|
(19)
|
(16)
|
(23)
|
(17)
|
(18)
|
(16)
|
0
|
|
| Other Operating Expenses |
14
|
17
|
8
|
7
|
7
|
12
|
11
|
17
|
(19)
|
|
| Operating Income |
(218)
N/A
|
(219)
-1%
|
(224)
-2%
|
(228)
-2%
|
(148)
+35%
|
(21)
+86%
|
71
N/A
|
122
+72%
|
182
+49%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
18
|
64
|
119
|
114
|
70
|
47
|
29
|
31
|
55
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(9)
|
(9)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
(200)
N/A
|
(155)
+22%
|
(114)
+27%
|
(123)
-9%
|
(79)
+36%
|
25
N/A
|
100
+295%
|
153
+52%
|
237
+55%
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
8
|
|
| Income from Continuing Operations |
(200)
|
(155)
|
(114)
|
(124)
|
(79)
|
26
|
100
|
153
|
244
|
|
| Net Income (Common) |
(200)
N/A
|
(155)
+22%
|
(114)
+27%
|
(124)
-9%
|
(79)
+36%
|
26
N/A
|
100
+291%
|
153
+52%
|
244
+60%
|
|
| EPS (Diluted) |
-0.68
N/A
|
-0.46
+32%
|
-0.34
+26%
|
-0.37
-9%
|
-0.24
+35%
|
0.08
N/A
|
0.31
+287%
|
0.47
+52%
|
0.76
+62%
|
|
Switch to:
Switch to:
See Also
Discover More
